Craft

StemCyte

Revenue

$25 M

Y, 2014

StemCyte Summary

Company Summary

Overview
StemCyte is a biotechnology company specializing in collecting, processing, and banking umbilical cord blood stem cells. It offers cord blood, tissues, human leukocyte antigen (HLA), and newborn genetic analysis (NGA) banking services for therapeutic use, including cancers, blood disorders, immune systems, and genetic disorders.
Type
Private
Status
Active
Founded
1997
HQ
Baldwin Park, CA, US | view all locations
Website
https://stemcyte.com
Cybersecurity rating
Sectors

Key People

  • Jonas Wang
  • Tong-Young Lee

    Tong-Young Lee, Chief Executive Officer

  • Joseph Rosenthal

    Joseph Rosenthal, Chief Medical Officer

Operating MetricsView all

Transplant Units Shipped to Date

2.3K
3.7%

May, 2024

Cord Blood and Cord Tissue Units Stored

50K

Aug, 2015

Transplant Centers Served

350

May, 2024

LocationsView all

3 locations detected

  • Baldwin Park, CA HQ

    United States

    13800 Live Oak Avenue

  • Ahmedabad, GJ

    India

    Plot No.1A, Bhat GIDC Estate

  • Taipei, New Taipei City

    Taiwan

    No 4, Lane 15, Wen-Hua 1st Road, Sec I, 244

StemCyte Financials

Summary Financials

Revenue (Y, 2014)
$25.0M

Footer menu